Results 111 to 120 of about 48,854 (243)
Influence of the CYP2D6*10 allele on the metabolism of mexiletine by human liver microsomes [PDF]
, 2001 Chiaki Senda +7 more
openalex +1 more source
Prospective assessment of CYP2D6 by genotyping, phenotyping and measurement of tamoxifen, PD 05-09 4-hydroxy-tamoxifen and endoxifen in breast cancer patients treated with tamoxifen. [PDF]
, 2010 Tamoxifen (tam) is a widely used endocrine therapy in the treatment of early and advanced stage breast cancer in women and men. It is a pro-drug having weak affinity with the estrogen receptor and needs to be converted to its main metabolite, endoxifen ...
Berthod, G. +10 more
core
Разработка и регистрация лекарственных средств, 2019 Simultaneous quantification method of assaying main CYP isoforms substrates-markers and their metabolites in urine using HPLC-MS/MS was developed to determine activity of following isoforms: caffeine/paraxanthine for CYP1A2, losartane/E-3174 for CYP2C9 ...
E. A. Egorenkov, V. V. Smirnov
doaj
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors [PDF]
, 2015 J K Hicks +15 more
openalex +1 more source
Metabolism of CYP2D6 substrate, antihistaminic mequitazine in DA rats.
, 1997 Katsunori Nakamura
openalex +2 more sources
Genetic polymorphisms of CYP2D6*10 and CYP2C19*2,*3 are not associated with prognosis, endometrial thickness, or bone mineral density in Japanese breast cancer patients treated with adjuvant tamoxifen [PDF]
, 2009 Masatsugu Okishiro +5 more
openalex +1 more source